Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-057474
Filing Date
2012-11-07
Accepted
2012-11-07 19:13:53
Documents
2
Period of Report
2012-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd359831.html 3  
1 FORM 3 rrd359831.xml 3 1526
2 POWER OF ATTORNEY rrd322869_365018.htm EX-24. 5384
  Complete submission text file 0001181431-12-057474.txt   8582
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Mahatme Sandesh (Reporting) CIK: 0001511034 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 121188108